Towards a durable RNAi gene therapy for HIV-AIDS
- PMID: 19236246
- DOI: 10.1517/14712590802653619
Towards a durable RNAi gene therapy for HIV-AIDS
Abstract
Background: RNA interference (RNAi) can be employed as a potent antiviral mechanism.
Objective: To discuss RNAi approaches to target pathogenic human viruses causing acute or chronic infections, in particular RNAi gene therapy against HIV-1.
Methods: A review of relevant literature.
Results/conclusions: The future of antiviral RNAi therapeutics is very promising. RNAi was discovered only a decade ago, and although we are still in the early days, the first clinical trials are already ongoing.
Similar articles
-
Toward a durable anti-HIV gene therapy based on RNA interference.Ann N Y Acad Sci. 2009 Sep;1175(1):3-14. doi: 10.1111/j.1749-6632.2009.04972.x. Ann N Y Acad Sci. 2009. PMID: 19796072 Free PMC article. Review.
-
RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.Antivir Chem Chemother. 2009;19(6):221-33. doi: 10.1177/095632020901900602. Antivir Chem Chemother. 2009. PMID: 19641231 Review.
-
Toward a durable treatment of HIV-1 infection using RNA interference.Prog Mol Biol Transl Sci. 2011;102:141-63. doi: 10.1016/B978-0-12-415795-8.00001-5. Prog Mol Biol Transl Sci. 2011. PMID: 21846571 Review.
-
Gene therapy strategies to block HIV-1 replication by RNA interference.Adv Exp Med Biol. 2015;848:71-95. doi: 10.1007/978-1-4939-2432-5_4. Adv Exp Med Biol. 2015. PMID: 25757616 Review.
-
RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.Methods Mol Biol. 2011;721:293-311. doi: 10.1007/978-1-61779-037-9_18. Methods Mol Biol. 2011. PMID: 21431693
Cited by
-
Silencing sexually transmitted infections: topical siRNA-based interventions for the prevention of HIV and HSV.Infect Dis Obstet Gynecol. 2014;2014:125087. doi: 10.1155/2014/125087. Epub 2014 Jan 12. Infect Dis Obstet Gynecol. 2014. PMID: 24526828 Free PMC article. Review.
-
The state of gene therapy research in Africa, its significance and implications for the future.Gene Ther. 2017 Sep;24(9):581-589. doi: 10.1038/gt.2017.57. Epub 2017 Jul 10. Gene Ther. 2017. PMID: 28692018 Free PMC article. Review.
-
Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances.Pharmaceutics. 2021 Aug 19;13(8):1294. doi: 10.3390/pharmaceutics13081294. Pharmaceutics. 2021. PMID: 34452255 Free PMC article. Review.
-
Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice.Mol Ther. 2011 Dec;19(12):2228-38. doi: 10.1038/mt.2011.207. Epub 2011 Sep 27. Mol Ther. 2011. PMID: 21952167 Free PMC article.
-
Current progress in the development of RNAi-based therapeutics for HIV-1.Gene Ther. 2011 Dec;18(12):1134-8. doi: 10.1038/gt.2011.149. Epub 2011 Sep 29. Gene Ther. 2011. PMID: 21956690 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical